abstract |
The invention relates to the use of polyvinyl pyrrolidone (PVP) for the modulation of drug release kinetics from hydrophilic polymer matrix tablets, in particular hydroxypropyl methyl cellulose (HPMC) matrix tablets. Another aspect of the invention is a method of drug release from a hydrophilic polymer matrix tablet, for example a hydroxypropyl methyl cellulose (HPMC) and compositions thereof. |